CytoDyn Inc. Share Price Other OTC
Equities
CYDY
US23283M1018
Biotechnology & Medical Research
Sales 2022 | 0.27 22.18 | Sales 2023 | - | Capitalization | 239M 19.97B |
---|---|---|---|---|---|
Net income 2022 | -211M -17.6B | Net income 2023 | -79M -6.59B | EV / Sales 2022 | 98,95,24,989 x |
Net Debt 2022 | 32.57M 2.72B | Net Debt 2023 | 33.01M 2.75B | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.02
x | P/E ratio 2023 |
-2.52
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.15% |
Latest transcript on CytoDyn Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 17/11 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | 01/02 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 03/23/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 13/22/13 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 24/22/24 |
Karen Brunke
BRD | Director/Board Member | 72 | 01/22/01 |
1st Jan change | Capi. | |
---|---|---|
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.89% | 22.18B | |
-16.67% | 21.2B | |
-9.33% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |